In Alzheimer's disease, misfolded tau protein propagates through the brain in a prion-like manner along connected circuits. Tauopathy correlates with significant neuronal death, but the links between tau aggregation, propagation, neuronal dysfunction and death remain poorly understood, and the direct functional consequences for the neuron containing the tau aggregates are unclear. Here, by monitoring individual neurons within a minimal circuit, we demonstrate that misfolded tau efficiently spreads from presynaptic to postsynaptic neurons.
Neurofibrillary tangles (NFTs), a pathological hallmark of Alzheimer's disease (AD), consist of insoluble aggregates of hyperphosphorylated tau protein. In AD, NFTs accumulate first in the entorhinal cortex, and with disease progression they appear in neighbouring regions such as the hippocampus, followed by the neocortex in later stages 1 . The neuroanatomical localisation of NFTs in AD brains suggests that tau pathology propagates through the brain along anterograde connected brain circuits [2] [3] [4] . Indeed, it is well established that pathogenic tau spreads between cells in vitro 5, 6 and in vivo 4, 7, 8 in a prion-like manner, inducing the misfolding of native tau 5, [9] [10] [11] . Tau seeds, the tau species that template a misfolded conformation to native tau, are thought to be monomers or lower molecular weight oligomers rather than the high molecular weight tangles observed at late stages of disease, but their exact nature is still under debate [12] [13] [14] [15] [16] . Moreover, experiments using AD brain extracts to seed the misfolding of tau reported the existence of distinct pathological tau strains 6 .
Pathogenic tau causes cell death both in vivo 4 and in vitro 17, 18 . Therefore, it has been suggested that one mechanism for the propagation of tau pathology is release following the disintegration and death of the tangle-bearing neurons 19 . In contrast, recent studies have
shown that intact neurons exist in areas of pathology propagation in mouse models 20 , and have detected tau species capable of seeding misfolding in brain areas free of tangle pathology in human brains 21 . This suggests potential release of pathogenic tau from living neurons. However, loss of neurons is progressive within areas affected by degeneration, and as a consequence the in vivo studies were short of the resolution required to identify individual tau-propagating neurons.
In experimental paradigms, exogenous pre-formed recombinant tau fibrils or extracts from brains with tauopathy are added to neurons to investigate the mechanisms underlying tau pathology transmission. Studies using such exogenous tau preparations have shown that tau aggregates are internalised into primary neurons, can be trafficked both anterogradely and retrogradely along axons, and spread to and between connected cells [22] [23] [24] . However, these studies did not examine the functional outcome of tau misfolding, aggregation and propagation within neurons. In this study, we created a minimalistic neuronal circuit within a compartmentalised microfluidic device to investigate tau misfolding and propagation at single cell resolution. We show that a phosphomimetic tau, tau E14 , in which 14 diseaserelevant serine/threonine residues have been mutated to glutamate to mimic phosphorylation 25 , misfolds and aggregates in the absence of exogenous seeds. Misfolded tau E14 seeds template a rapid and efficient prion-like misfolding of native tau, and transmit a conformational change of tau between intact, connected neurons with high efficiency. This suggests that propagation of misfolded tau occurs between live, functioning neurons in very early stages of tau pathology prior to neuronal degeneration. In the context of AD, our findings imply that transmission of misfolded tau through the brain occurs between viable neurons and may precede detectable symptoms; it thus may present a disease modifying target for mild cognitive impairment.
Results

Phosphomimetic tau spontaneously aggregates in cultured neurons.
Hyperphosphorylation of tau is associated with pathology. (Fig. 1e) . In order to analyse the appearance of tau aggregation within the axon we generated fluorescence distribution profiles along individual axons. This confirmed highly variable fluorescence intensities along axons of tau E14 expressing neurons, in comparison to a smooth fluorescence distribution in tau WT expressing neurons (Fig.1d, S1c ).
Neurons were scored as positive for aggregation along the distal axon based on this differential variation (Fig. 1d, S1 , supplemental methods). This analysis showed that at DIV14, 56.0 ± 7.7% of the tau E14 expressing axons have developed aggregates, whereas the distal axons of tau WT expressing neurons remained aggregate-free (Fig. 1f) . This demonstrates that pseudohyperphosphorylation of tau is sufficient to induce misfolding and aggregation of tau.
Tau aggregation efficiently propagates to connected neurons.
MC1 staining to visualise misfolded tau revealed that neurites in the vicinity of a tau E14 expressing axon were positive for misfolded tau, whereas those surrounding an axon expressing tau WT remained MC1 negative (Fig. 1e , blue arrows). This suggests that tau
E14
expression is sufficient not only to induce misfolding and aggregation of tau within the axon, but also to spread as a seed to neighbouring cells and potentially recruit endogenous tau.
To more precisely investigate the propagation between neurons we co-cultured tau
expressing 'donor' cells and tau WT 'acceptor' cells within a microfluidic device that allows co-culture of two spatially distinct neuronal populations. These two populations can be manipulated independently but are in contact via projecting axons 22, 28 . This enabled us to separate tau E14 and tau WT expressing neurons and identify individual connecting cells ( Fig.   2a-c) . We used fluorescence microscopy to analyse the time course of aggregate formation and propagation in vitro. Aggregates were first detected at DIV8 in the axons of tau
expressing donor neurons (Fig. 2e) , and the number of axons positive for tau aggregation steadily increased at a rate of 4.9 ± 0.6% per day, until a plateau was reached at DIV18 with 75.5 ± 6.4% of axons containing visible tau aggregates (Fig. 2e) propagates to connected cells.
Distinct neuronal subcompartments display a differential vulnerability to tau misfolding and aggregation.
In both the donor (not shown) and acceptor neurons, tau aggregates first appeared in the distal axon, and were later detected in the somatodendritic compartment (Fig. 3a) . For distal axonal misfolding and aggregation to occur in the acceptor neuron within the oriented setup of the microfluidic chamber (Fig. 2a,b) , seeds that have been internalised at the somatodendritic compartment must have first trafficked or propagated to the distal axon.
Indeed, we detected GFP-tau E14 positive accumulations in the somata of RFP-tau WT expressing neurons (Fig. 3b,d , and movie S1), while no aggregates were visible within the somata of tau WT expressing neurons connected to GFP expressing cells (Fig. 3c, . We confirmed that the misfolding of tau was propagated to the distal axons of acceptor cells using MC1 staining (Fig. 3f ). This demonstrates that as well as being sufficient for tau aggregate formation, pseudohyperphosphorylation of tau is sufficient for the prion-like propagation of the conformational change to surrounding neurons. Interestingly, we never detected tau aggregation at the proximal axonal segment of either donor or acceptor neurons, and this axonal subcompartment also remained negative for MC1 staining (Fig. 3f) . Together with the observation that visible tau aggregates were first observed in the distal axon of acceptor cells, despite receiving the seeds at the somatodendritic compartment, this suggests that (i) smaller seeds distribute throughout the neuron prior to the formation of visible aggregates, (ii) that tau in the distal axon is most susceptible to aggregation and (iii) misfolded tau does not accumulate in, or is rapidly cleared from, the proximal axonal region.
Intracellular tau aggregates are not acutely toxic.
In vivo models show that progression of tau pathology is accompanied by significant neuronal death 4 , and indeed advancement of AD is associated with brain atrophy caused by extensive neuronal loss 1 . Furthermore, exogenous addition of tau is toxic to neurons in vitro 17, 18, 29 , suggesting that tau pathology is associated with neuronal death. However, the direct functional consequence of tau misfolding and aggregation on individual neurons has not yet been identified. Here, we monitored the formation and propagation of tau pathology at single cell level, and thus were able to analyse the state of tau E14 expressing cells at the time of misfolding and active tau pathology transmission. Tau E14 expressing donor neurons at DIV14 appear intact and undistinguishable from surrounding untransfected cells, as judged by differential interference contrast (DIC) imaging, exhibiting a smooth and intact plasma membrane and healthy nuclear morphology (Fig. 4a) . Loss of synaptic connections has been identified as one of the earliest cellular changes in Alzheimer's disease 30, 31 . As tau misfolding and aggregation first occur in the distal axon we visualised a presynaptic marker, synapsin, to assess the density of presynaptic sites. We did not observe any overt differences in the number of presynaptic sites between tau E14 expressing neurons and their untransfected surrounding axons (Fig. 4b ). This suggests that misfolded tau and tau aggregates are not acutely toxic to hippocampal neurons. Indeed, we did not observe disintegration or death of these neurons across the observed time course, to DIV26. Even at DIV42, five weeks after the first detected propagation of tau pathology to connected neurons ( Fig. 2e) , the neurons remained intact as judged by DIC imaging and nuclear morphology ( Fig. 4c) This demonstrates that energy-dependent processes were intact, and suggests that neurons remain electrically competent in the presence of misfolded and aggregated tau. To investigate the electrical competence in more detail, we performed an electrophysiological analysis on the cells with whole-cell patch clamp. When current clamped, both tau E14 and tau WT expressing neurons were capable of responding to positive current injections with action potentials of a similar amplitude (Fig. 6c ). There were no significant differences in the minimum current required to evoke a single action potential (rheobase); with tau E14 and tau WT expressing neurons requiring 77 ± 40 pA and 83 ± 25 pA respectively (p = 0.53) (Fig. 6d) . We further found no significant differences in the input resistance between tau E14 (694 ± 367 MW) and tau WT (578 ± 101 MW) expressing cells, (p = 0.64) (Fig. 6e) , and the resting membrane potentials of tau E14 (-73.8 ± 2.4 mV) and tau WT (-73.3 ± 3.5 mV) expressing neurons do not differ, (p = 0.58) (Fig. 6f ). This shows that despite possessing and transmitting tau pathology, donor neurons retain their ability to maintain a normal resting membrane potential and fire action potentials to the same extent as tau WT control neurons.
Together, these data demonstrate that phosphomimetic tau misfolds and aggregates in the absence of exogenous seeds, and that transmission of tau misfolding to healthy neurons is an active and efficient process that is accompanied by a selective neuronal dysfunction, but the presence of misfolded and aggregated tau does not compromise neuronal excitability and is compatible with longer-term neuronal viability.
Discussion
Using a minimalistic in vitro model of connected neurons, we have shown that phosphomimetic tau misfolds in the absence of exogenous seeds and forms tau aggregates.
This tau pathology is robustly propagated from the neuron expressing the phosphomimetic protein to surrounding neurons. We further demonstrate that neurons containing tau aggregates display no neurodegeneration. Instead, they remain intact and retain electrical competence at the time of tau transmission. While the presence of tau aggregates leads to a selective impairment in axonal transport, this does not impact on neuronal viability. These observations show that tau misfolding and aggregation do not induce acute toxicity in hippocampal neurons.
Previous studies examining the mechanisms of tau propagation have added varying exogenous species of tau seeds to induce misfolding 5, 11, 22 . We here show that the negative charges conferred by a phosphomimetic tau that simulates hyperphosphorylation at 14 disease-related sites are sufficient to initiate misfolding within a living neuron, in absence of exogenous seeds. This misfolded tau forms aggregates and propagates tau seeds from presynaptic to postsynaptic neurons. AD is associated with an imbalance of kinase and phosphatase activities 37 that leads to aberrant hyperphosphorylation of tau, and these hyperphosphorylated species are detected within NFTs 38 . Our observation implies that a posttranslational modification such as phosphorylation in isolation is sufficient to initiate the cascade of tau misfolding, aggregation and propagation.
The compartmented setup of our propagation assay allowed the monitoring of individual neurons that formed or received misfolded tau species. This showed unexpectedly fast and robust tau propagation from neuron to neuron in vitro, with a near complete transmission efficiency. This is at odds with findings that show Braak staging progresses in patients over a matter of years to decades 39 . Our study used pure murine hippocampal neurons, cultured in the absence of other cell types. The efficiency of transmission may be due to a lack of a glial population, which display tau pathology in patients with tauopathy [40] [41] [42] , as well as in in vivo 43 and in vitro 44 models of tauopathy. Therefore, glial populations may play a role in clearance of secreted pathogenic tau, and their absence in our setup revealed an under-appreciated intrinsic high efficiency of tau release and re-uptake in neurons. This high efficiency of neuron-to-neuron tau propagation within our connected system further suggests that a physiological process of protein transmission may be at play that is occurring in healthy neurons, but revealed under pathological conditions through transmission of a conformationally altered species. This idea is reinforced by the observation that healthy tau is secreted from intact neurons in an activity-dependent manner shown to act as a barrier for select isoforms of tau proteins, potentially due to increased microtubule dynamics in this area 46, 47 , which may play a role in the lack of retention of misfolded tau within this region. However, it is clear that misfolded tau is able to cross this barrier and cause distal axon pathology.
Our ability to monitor tau misfolding within single cells allowed us to directly assess the physiological effects that tau pathology has on neurons. We found that despite containing misfolded tau and tau aggregates for prolonged periods of time, neurons remained alive, intact, and retained energy dependent processes, displaying a selective dysfunction in axonal transport. Previous studies showed that acutely added tau seeds can induce toxicity and cell death via calcium dysregulation 17, 18, 29 . However, we found that neurons containing tau aggregates had intact calcium fluxes, physiological resting membrane potentials, and were able to elicit action potentials. Furthermore, we also showed cell survival for extended periods of time after tau aggregate formation, as we observed neuronal viability for weeks after initial misfolding and propagation. Our data therefore shows that misfolded tau and tau aggregates are not immediately toxic to neurons. Instead, they initiate a selective axonal transport dysfunction that precedes synaptic loss, and in isolation does not result in axonal degeneration or cell death.
Furthermore, we provide the first direct evidence for the suggestion that disintegration or death of neurons containing tau seeds does not need to occur in order to propagate tau pathology 20 , and show that tau propagation precedes synaptic or neuronal degeneration. This is in agreement with a recent study showing that spread of tau seeds precedes tangle pathology in the human brain 21 . In addition, prion seeds are detectable throughout all brain regions in mice infected with prion disease, while degeneration is region specific 48 . Together, these data and our findings suggest that the idea that presence of misfolded protein in isolation does not determine neurodegeneration 48 may hold true across different protein misfolding diseases. This information, combined with a potential physiological transmission of tau between neurons, raises the possibility that at the stage of diagnosis, tau seeds may have spread throughout wider brain regions, having passed the time point where a sequestration of free tau seeds in isolation is effective in halting disease progression.
However, our data imply that because the affected neurons are intact and viable at the early stages of tau misfolding, and because neither hyperphosphorylated tau nor tau aggregates are immediately toxic to neurons, neurons with tau pathology could potentially be rescued with a therapeutic disease modifier.
Online methods
Plasmids
The following plasmids were used: pRFP-N1, pEGFP-C3 (Clontech), pRK5-EGFP-tau WT and pRK5-EGFP-tau E14 were a gift from Karen Ashe 25 (Addgene plasmids #46904 and #46907), 
Cell culture and transfection
All experiments were carried out in accordance with the Animals (Scientific Procedures) Act 1986 set out by the UK Home Office. Primary cultures were prepared as described previously 51 . Briefly, hippocampal neurons were isolated from embryonic day 15-18 C57BL/6 mouse brains. Dissociated neurons were plated in Neurobasal medium supplemented with 2% B27 and 0.5 mM GlutaMAX (Gibco) at a density of 7000 cells/µl in microfluidic devices, and 150,000 cells/ml in glass bottom dishes. Partial medium changes were performed on the devices every 2-3 days. On DIV1, neurons were transfected using Lipofectamine 2000 as described previously 51 .
Microfluidic devices
Custom microfluidic devices were manufactured based on existing designs 52,53 (see supplemental file 2). Devices were replicated using polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning) with a 10:1 ratio of elastomer to curing agent. PDMS mix was cured at 60 °C for at least 90 minutes, and inlets were punched using a 5-mm-diameter biopsy punch 
GFP-Tau
E14 or GFP-Tau WT and imaged at DIV14, using 100 ms exposure and 2% light.
Images were taken at 2 Hz for 6 minutes. After 3 min, 1 µM tetrodotoxin (Sigma) was added, followed after 2 minutes by 100 mM KCl.
Image analysis
Overview images were reconstructed from multiple single images using Autostitch software (University of British Columbia). Images were processed and analysed using ImageJ software (NIH), and its plugins NeuronJ 54 and Iterative Deconvolution (Bob Dougherty).
Axonal length was defined as the longest axonal branch from the longest neurite. Distal axon was defined as a 75 µm stretch of axon at, or near to, the terminal of an axon branch, and proximal axon was defined as a 75 µm long stretch of axon measured beyond the first 50 µm of axon protruding from the cell body, therefore beyond the axonal initial segment (Fig. S2) .
Intensity profiles along a line were generated using plot profile, and kymographs using the MultipleKymograph plugin on ImageJ. Lysosomes which displaced greater than 50 µm over the course of the time lapse were considered moving and all others stationary. For calcium imaging, a circle was drawn around the soma of the expressing neuron, and analysis was generated using the 'intensity v time' stacks function of ImageJ.
Aggregate analysis was performed using Matlab. Briefly, the fluorescence intensity values of paired control and experimental axons were measured. A baseline of each individual axon is set by subtracting the 10 th percentile from all values, and any point lying outside 5 times the mean of the deviations of all control axons from the experiment is scored positive, i.e. an aggregate containing point. The percentage axonal stretch scoring positive is determined, and any axon with >10% of its length outside the allowed deviation is scored as aggregate containing (Fig S1) .
Electrophysiology
Cells were cultured on coverslips and transfected with RFP-Tau WT or RFP-Tau E14 . For patch clamp recording cells were perfused with oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (CSF) which contained (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 2
MgSO4, 2 CaCl2, 26 NaHCO3, and 10 glucose, pH 7.3-7.4. at a rate of 1-2 ml/min. 
Statistics
Statistical analysis was performed using GraphPad Prism 6 (Ver 6.00m Graph Pad Software Inc.). All experiments contain data from a minimum of 3 independent dissections, with an individual experiment defined as the cells derived from embryos of one mouse. All data in text are expressed as mean ± SD. Statistical analyses were performed using a t-test for comparison of two groups or an ANOVA for comparison of 3 or more groups, with details provided in figure legends.
Data availability
The data that support the findings of this study are presented in the paper and are available from the corresponding author upon reasonable request. 
Supplementary material
Supplemental file 1.
Supplemental methods: Aggregate analysis
Aggregate analysis was performed in Matlab (see script below). Plot profiles of 75 µm long axonal stretches were generated from 16-bit images, and the pixel intensity values were analysed (Fig. S1) 
Supplemental file 2.
Images of mask layers for the microfluidic device, provided as DraftSight (.dwg) files.
Layer 1 -height 3 µm.
Layer 2 -height 50 µm.
Supplemental movies
Movie S1. Tau 
